| mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
-0.0026 |
0.9 |